Clinical Trial Update: Use of Cidofovir for Recurrent Respiratory Papillomatosis [Phase 4]

View source ↗

Summary

Clinical trial update for cidofovir in recurrent respiratory papillomatosis (Phase 4) completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Papillomatosis

Drugs mentioned

• Cidofovir (cidofovir)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Recurrent Respiratory Papillomatosis | Phase 4 | Status: COMPLETED | Results posted: 2017-07-18